No Detail Found!

New multiple therapy of resistant and relapsing dermatophyte infections during epidemic status

Author(s)
Khalifa E Sharquie Department of Dermatology, College of Medicine, University of Baghdad, Medical City Teaching Hospital,Baghdad,Iraq
Raed I Jabbar Department of Dermatology, Fallujah Teaching Hospital, Al-Anbar Health Directorate, Anbar, Iraq
Abstract
Background Resistant dermatophytosis is now running in many countries where fungal skin infection is a major health problem like Iraq and neighboring countries. Objective To evaluate the efficacy of a novel therapeutic regimen in the management of resistant dermatophytosis using multiple drug therapies. Methods This is a prospective therapeutic research where 400 cases with varying kinds of dermatophytosis were included and managed by new 2 phases of therapy, each four weeks period and as follow: Phase one using combination of oral terbinafine and oral ketoconazole and topical terbinafine cream plus selenium sulfide shampoo. While phase two including combination of oral terbinafine and oral itraconazole and topical terbinafine cream plus ketoconazole shampoo to achieve complete cure rate. Follow-up was done for eight weeks to record relapse of fungal infection. Results This study included 400 patients with chronic relapsing dermatophytosis, 250 (62.5%) males and 150 (37.5%) females, their ages ranged from 6-70 years. The duration of the disease ranged from 6-32 months with a mean of 11 months. The response to the phase one therapeutic regimen started after 5-7 days by decreasing in the redness, itching, inflammation, and scales. An obvious response was seen at the end of the first two weeks while full complete recovery response was achieved after four weeks. While phase two also showed 100% obvious cure rate. Follow up for eight weeks showed 2% relapse rate. This combination was well tolerated with no serious systemic or topical adverse effects were recorded in most of the patients. Conclusion This new therapeutic multiple drug therapy is effective in all included types of dermatophytosis especially with chronic resistant course of the disease with very low relapse rate.
Publication Details
Page(s) 464-471
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 32, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
Ketoconazole, Terbinafine, Chronic, Antifungal, Dermatophytosis, Itraconazole
0

Citations

0

Downloads

30

Views